Content Detail

• Content META

  Title	HumanCo Investments Sends Letter to the Board of Directors of Grove Collaborative By HumanCo Investments Jul 8, 2025 13 hrs ago
  ID	11485410
  External ID	7890779419
  Author	Unknown
  Published Date	July 9, 2025, 2:43 p.m.
  Summary	Believes Grove could be conservatively valued at ~0.70x - 0.90x 2025E revenue in such a transaction, which equates to a ~90 - 140% premium to the Company's current share price of or ~$2.25 per share o
  Tags	press-release
  URL	https://www.cadillacnews.com/online_features/press_releases/humanco-investments-sends-letter-to-the-board-of-directors-of-grove-collaborative/article_81f45ed0-158b-57a4-8afa-44b0e155d47e.html
  Sentiment	Negative: 0.01415    Neutral: 0.20096    Positive: 0.78489
  Relevance	0.08333

• Content Details

  Content ID	7336955
  Key	feed38c7-4d66-48a9-987d-4d7867cab847
  Content	Believes Grove could be conservatively valued at ~0.70x - 0.90x 2025E revenue in such a transaction, which equates to a ~90 - 140% premium to the Company's current share price of or ~$2.25 per share on a fully diluted basis. MIAMI July 8, 2025 /PRNewswire/ -- HumanCo Investments ("HCI"), which is affiliated with investors that own more than 5% of Grove Collaborative Holdings, Inc. (NYSE: GROV) ("Grove" or the "Company") and are among the Company's largest shareholders, today sent a public letter to Grove's Board of Directors. The letter called on the Board to conduct a comprehensive review of strategic alternatives, including a sale to a larger strategic company or financial sponsor, or a transformative merger with a profitable company. The letter notes that HCI, a recognized thought leader in the health and wellness investment space, is an avid supporter of Grove's mission to be the premier, online non-toxic marketplace for household, personal care and wellness products. HumanCo Investments believes Grove, which is at the center of the clean-living secular trend, has developed a significant competitive moat over the past 10+ years, one that cannot be replicated quickly or without a significant amount of capital. Furthermore, Grove is in good financial health, having reached profitability and operating cash flow generation over the past year, as well as having minimal debt with no near-term solvency issues. However, the Company has become deeply undervalued in the public market due to a lack of investor relevance as a result of its small market capitalization and limited float. This irrelevance has only been amplified by Grove's inability to pursue a strategy that balances both growth and profitability due to its significant operational and public cost burden that cannot be materially reduced as a standalone public company. HumanCo Investments believes that Grove will be able to reach its full potential by partnering with another company that has the necessary capital and operational infrastructure in order for the Company to properly invest in a long-term, growth-oriented strategy. The full text of the letter is as follows: Letter to the Board of Directors July 8, 2025 Board of Directors Grove Collaborative Holdings, Inc. 1301 Sansome Street San Francisco, CA Dear Members of the Board: We are writing to you on behalf of investors affiliated with HumanCo Investments LLC (collectively, "HCI" or "We"). HCI has been one of the largest shareholders of Grove Collaborative Holdings, Inc. ("Grove" or the "Company") since November 2022 , currently owning more than 5% of the Company's common shares outstanding. We are also an avid supporter of the Company's mission to be the premier online, non-toxic marketplace for household, personal care and wellness products. As a significant shareholder and recognized thought leader in the health and wellness investment space, we are writing to you today to suggest the necessary steps we believe Grove must take to capture the extraordinary opportunity in front of it. Grove has the potential to be the leading digital marketplace for non-toxic products within the accelerating secular trend toward cleaner living. Over the last 10+ years, Grove has developed a unique health-oriented marketplace, with a strong competitive moat and the following attributes: 1) A foundation as the first marketplace dedicated to non-toxic, sustainable and plastic-free products; 2) A large base of high-retention customers, whose trust has been earned over 10+ years of strict product guardrails; 3) An extensive portfolio of, and relationships with, the cleanest, least toxic brands in the marketplace; and 4) Substantial investment in the brand, high value customers and supply chain infrastructure and logistics. However, we believe Grove is deeply undervalued by the public market. Despite its strong competitive moat, as well as its 700,000 active customers, expected annual revenue of ~$185 million (according to analyst estimates) and over $650 million of capital invested in the business over its lifetime , Grove currently has a fully diluted enterprise value of ~$75 million (0.4x EV / 2025E revenue) This represents an over 95% decline from when it went public at a $1.5 billion valuation, despite being positioned at the center of the high-growth, clean-living trend in the CPG category. Most importantly, Grove was EBITDA positive in FY 2024 and expects to be breakeven in FY 2025 (mid-point of company guidance), has been operating cash flow positive 3 of the last 4 quarters, has minimal debt, no near-term solvency issues and over $500 million in NOLs. In the hands of someone else, with the right M&A or as a private company, we believe Grove is worth substantially more. HCI believes the shareholder returns and financial performance have been impaired by several significant factors, including a lack of investor relevance given Grove's small market capitalization, limited public float and lack of equity research coverage. This lack of investor relevance and interest has only been amplified by a misguided strategy over the past three years that was aimed entirely towards cutting costs and achieving profitability vs. balancing growth and profitability. We believe Grove must find a partner who has the necessary capital and operational infrastructure for the Company to properly invest in a long-term, growth-oriented strategy. We believe Grove could be conservatively valued at ~0.70x - 0.90x 2025E revenue (according to analyst estimates) in such a transaction, which equates to a ~90 - 140% premium to the Company's current share price of or ~$2.25 per share on a fully diluted basis. As such, we believe the Board is obligated to undertake a comprehensive review of strategic alternatives, including a potential sale to a larger strategic buyer, a take-private transaction with a financial sponsor, or a transformative merger with a profitable company, which could allow Grove to utilize its $500 million+ of NOLs. The Generational Opportunity in Non-Toxic Living We stand at an inflection point in consumer behavior. Millions of families are desperately seeking safer, cleaner alternatives to everyday products, yet they face a fragmented and confusing marketplace. Amazon overwhelms with choice but offers no curation. Walmart provides convenience but lacks credibility in clean living. Target touches the surface but misses the depth. Grove alone possesses the trust, expertise, and platform to become the definitive digital marketplace for curated, trusted non-toxic living. Consider the market dynamics: Post-pandemic health consciousness has created permanent behavioral change; 69% of consumers indicated they are more likely to buy from companies that have strong health and wellness across their entire product portfolio as per Nielsen's 2025 Global Health & Wellness Survey; According to Nielsen, nearly 50% of consumers indicated they are looking for products with safety precautions, such as less plastic, fewer synthetic chemicals and non-toxic ingredients 73% of millennials will pay more for sustainable products per a 2024 Nielsen survey; Sustainable products drove ~33% of all CPG growth over a year , despite representing <20% of market share as per an NYU Stern Center for Sustainable Business study; and Current regulatory momentum against harmful chemicals is accelerating consumer demand. This is not just a market opportunity – it is a societal imperative. Families need a trusted guide through the maze of greenwashing and confusing labels. Grove has spent a decade and over $650 million building exactly what the consumer demands. Grove's Unmatched Strategic Assets Grove possesses competitive advantages that would take years and hundreds of millions of dollars to replicate: Market Position The original and most authentic player in online non-toxic commerce; First-mover advantage in the most powerful trend in the consumer category, which is still in its early innings; Brand synonymous with the clean-living movement; Trust at Scale 700,000 active customers with 86% of orders consisting of 1+ subscriptions (up from 78% 3 years ago – see appendix); Over 5 million customers acquired throughout Grove's lifetime; A decade of consistent, authentic commitment to rigorous product standards and customer service, resulting in an industry-leading NPS of 65 (see appendix); Curated Expertise Relationships with 200+ premium clean brands Proprietary knowledge of which products truly meet non-toxic standards; The only platform where consumers can shop with complete confidence; Well-Invested Tangible and Intangible Assets $350+ million invested in brand building and customer acquisition; Sophisticated logistics, supply chain, R&D and subscription capabilities; and Rich and highly valuable data on millions of health-conscious consumers. The Path Grove Has Taken Despite these remarkable assets, Grove's current trajectory does not match its potential. The Company has pursued a conservative strategy focused on cost-cutting and near-term profitability rather than capturing market leadership. While prudent in some respects, this approach risks missing a once-in-a-generation opportunity to define an entire category. There are several key indicators highlighting the significant cost-cutting as well as the unrealized potential: Quarterly revenue has contracted from $90.5M to $43.5M while the category explodes (see appendix); Quarterly marketing investment has dropped 91% since Q1 2022, amounting to only ~$3 million of advertising spend per quarter currently, precisely when brand building is most critical (see appendix); Customer acquisition halted just as millions seek non-toxic alternatives; and The company operates at subscale in a winner-take-all digital market. Grove's ability to take advantage of the opportunity in front of it has been largely hampered by a few significant uses of capital that can be rapidly reduced as a private company or as a part of a larger organization: SG&A – Grove's operational overhead has remained at ~52% of net revenue since Q1 2023, which HCI estimates could be materially reduced under the ownership of a larger platform (see appendix); and Public company costs – HCI estimates Grove would achieve at least $4.0 million in annual savings by not bearing these costs as a private company. This is not failure. It is untapped potential that can easily be unlocked. Grove has built the foundation; now it needs the resources and strategic vision to achieve its full potential. A Vision for Grove's Future Imagine Grove as it could be: The Trusted Authority : When parents wonder "Is this safe for my family?" Grove is the definitive answer. Every product vetted, every ingredient scrutinized, every brand verified The Discovery Platform : Emerging clean brands choose Grove first, knowing it is where conscious consumers shop. Grove becomes the kingmaker in non-toxic products The Educator : Through content, community, and curation, Grove teaches millions how to transition to cleaner living, building loyalty that transcends transactions The Innovation Partner : Grove's data and customer relationships drive product development, creating exclusive offerings that cannot be found elsewhere The Category Leader : With scale comes negotiating power, marketing efficiency, and the ability to make clean products accessible to all economic levels Strategic Alternatives to Unlock Value To achieve this vision and maximize value for its shareholders, Grove needs resources, scale, and strategic support. We believe the Board should immediately explore strategic alternatives that will unlock Grove's true potential: Strategic Partnership or Acquisition Partner with a larger organization that shares Grove's mission and can provide: Capital to invest in growth and market leadership Operational expertise in scaling digital marketplaces Distribution partnerships to expand reach Potential partners include: Major retailers seeking authentic entry into clean living CPG companies wanting direct-to-consumer capabilities E-commerce platforms looking to own vertical categories or deepen category leadership Transformative Merger Secure growth capital from mission-aligned investors Explore mergers with complementary businesses to achieve scale Utilize Grove's $500M+ in NOLs to structure tax-efficient combinations Private Ownership for Long-Term Building Remove quarterly pressure that constrains bold moves Eliminate public company costs to re-invest into growth Execute a 5-year plan to build the definitive non-toxic marketplace Our valuation analysis of comparable M&A transactions and publicly traded companies, which is centered around digital marketplaces with a health and wellness focus, suggests Grove could conservatively command a ~ 0.70 - 0.90x EV / 2025E revenue (according to analyst estimates) multiple ( ~$2.25 - 2.90 per share) in a transaction. This per share value represents a ~90 -140% premium to Grove's current share price of . More importantly, the right partner could help Grove achieve its mission at scale. The Moment of Decision Grove stands at a crossroads. One path leads to continued independence, but probable irrelevance as larger players eventually recognize and capture this market while Grove's publicly traded stock fails to deliver value to its stockholders. The other path leads to strategic partnership and the resources needed to define an entire category. It is incumbent on the Board to explore options that will create value for Grove's stockholders. The clean-living revolution is happening. The question is whether Grove will lead it or watch from the sidelines as others build what Grove pioneered. We respectfully request that the Board: F orm a Strategic Review Committee to explore all value-maximizing alternatives Engage a leading investment bank to assess acquiror interest Commit to a transparent process with regular shareholder updates Act with urgency – every month of delay is market share lost Respectfully, Ross Berman Managing Partner HumanCo Investments LLC Jason H. Karp Partner HumanCo Investments LLC A Personal Note from Jason H. Karp My life's work has been making healthy living accessible to all Americans. We invested in Grove because we believed it could become the foundation of the non-toxic movement. That belief remains stronger than ever. Grove's mission matters. Today, families still face challenges identifying which products are truly safe. Greenwashing misleads even informed consumers, and marketing often hides the presence of harmful chemicals. Grove stands apart by giving consumers a trusted source for clean products and straightforward, transparent information. This is not about financial engineering. It's about giving Grove the resources and platform to fulfill its destiny as the Amazon of clean living. The families who rely on Grove's curation, the brands that grow through its platform, and the movement that looks to its leadership are all watching. Let's not keep them waiting any longer. Disclaimer THE VIEWS EXPRESSED HEREIN REPRESENT THE OPINIONS OF HUMANCO INVESTMENTS LLC AND ITS AFFILIATES (COLLECTIVELY, "HCI") AS OF THE DATE HEREOF. HCI RESERVES THE RIGHT TO CHANGE OR MODIFY ANY OF ITS OPINIONS EXPRESSED HEREIN AT ANY TIME AND FOR ANY REASON AND EXPRESSLY DISCLAIMS ANY OBLIGATION TO CORRECT, UPDATE OR REVISE THE INFORMATION CONTAINED HEREIN OR TO OTHERWISE PROVIDE ANY ADDITIONAL MATERIALS, EXCEPT TO THE EXTENT REQUIRED BY APPLICABLE LAW. ALL OF THE INFORMATION CONTAINED HEREIN IS BASED ON PUBLICLY AVAILABLE INFORMATION WITH RESPECT TO GROVE COLLABORATIVE HOLDINGS, INC.(THE "COMPANY"), INCLUDING FILINGS MADE BY THE COMPANY WITH THE SECURITIES AND EXCHANGE COMMISSION ("SEC") AND OTHER SOURCES, AS WELL AS HCI'S ANALYSIS OF SUCH PUBLICLY AVAILABLE INFORMATION. HCI HAS RELIED UPON AND ASSUMED, WITHOUT INDEPENDENT VERIFICATION, THE ACCURACY AND COMPLETENESS OF ALL DATA AND INFORMATION AVAILABLE FROM PUBLIC SOURCES, AND NO REPRESENTATION OR WARRANTY IS MADE THAT ANY SUCH DATA OR INFORMATION IS ACCURATE. HCI RECOGNIZES THAT THERE MAY BE CONFIDENTIAL OR OTHERWISE NON-PUBLIC INFORMATION WITH RESPECT TO THE COMPANY THAT COULD ALTER THE OPINIONS OF HCI WERE SUCH INFORMATION KNOWN. NO REPRESENTATION, WARRANTY OR UNDERTAKING, EXPRESS OR IMPLIED, IS GIVEN AS TO THE RELIABILITY, ACCURACY, FAIRNESS OR COMPLETENESS OF THE INFORMATION OR OPINIONS CONTAINED HEREIN, AND HCI AND EACH OF ITS MANAGERS, OFFICERS, EMPLOYEES, REPRESENTATIVES AND AGENTS EXPRESSLY DISCLAIM ANY LIABILITY WHICH MAY ARISE FROM THE ACCOMPANYING LETTER (INCLUDING THE appendix thereto) AND ANY ERRORS CONTAINED HEREIN AND/OR OMISSIONS HEREFROM OR FROM ANY USE OF THE CONTENTS OF THE ACCOMPANYING LETTER (INCLUDING THE APPENDIX THERETO). EXCEPT FOR THE HISTORICAL INFORMATION CONTAINED HEREIN, THE INFORMATION AND OPINIONS INCLUDED IN THIS PRESENTATION CONSTITUTE FORWARD-LOOKING STATEMENTS, INCLUDING ESTIMATES AND FORECASTS WITH RESPECT TO, AMONG OTHER THINGS, THE COMPANY'S ANTICIPATED OPERATING PERFORMANCE, THE VALUE OF THE COMPANY'S SECURITIES, INDUSTRY TRENDS, GENERAL ECONOMIC AND MARKET CONDITIONS AND OTHER FUTURE EVENTS. YOU SHOULD BE AWARE THAT ALL FORWARD-LOOKING STATEMENTS, ESTIMATES AND FORECASTS ARE INHERENTLY UNCERTAIN AND SUBJECT TO SIGNIFICANT ECONOMIC, COMPETITIVE, AND OTHER UNCERTAINTIES AND CONTINGENCIES AND HAVE BEEN INCLUDED SOLELY FOR ILLUSTRATIVE PURPOSES. ACTUAL RESULTS MAY DIFFER MATERIALLY FROM THE INFORMATION CONTAINED HEREIN DUE TO REASONS THAT MAY OR MAY NOT BE FORESEEABLE. THERE CAN BE NO ASSURANCE THAT THE COMPANY SECURITIES WILL TRADE OR BE VALUED BY ANY PERSON AT THE PRICES THAT MAY BE IMPLIED HEREIN, AND THERE CAN BE NO ASSURANCE THAT ANY OPINION OR ASSUMPTION HEREIN IS, OR WILL BE PROVEN, CORRECT. THE ACCOMPANYING LETTER (INCLUDING THE APPENDIX THERETO) AND ANY OPINIONS EXPRESSED THEREIN SHOULD IN NO WAY BE VIEWED AS ADVICE ON THE MERITS OF ANY INVESTMENT DECISION WITH RESPECT TO THE COMPANY, COMPANY SECURITIES OR ANY TRANSACTION. THE ACCOMPANYING LETTER (INCLUDING THE APPENDIX THERETO) DOES NOT CONSTITUTE (AND MAY NOT BE CONSTRUED TO BE) A SOLICITATION OR OFFER BY HCI OR ANY OF ITS MANAGERS, OFFICERS, EMPLOYEES, REPRESENTATIVES OR AGENTS TO BUY OR SELL ANY COMPANY SECURITIES OR SECURITIES OF ANY OTHER PERSON IN ANY JURISDICTION OR AN OFFER TO SELL AN INTEREST IN FUNDS MANAGED BY HCI. THIS PRESENTATION DOES NOT CONSTITUTE FINANCIAL PROMOTION, INVESTMENT ADVICE OR AN INDUCEMENT OR ENCOURAGEMENT TO PARTICIPATE IN ANY PRODUCT, OFFERING OR INVESTMENT OR TO ENTER INTO ANY AGREEMENT WITH any person. AFFILIATES of HCI CURRENTLY BENEFICIALLY OWN AND/OR HAVE AN ECONOMIC INTEREST IN AND MAY IN THE FUTURE BENEFICIALLY OWN AND/OR HAVE AN ECONOMIC INTEREST IN, COMPANY SECURITIES. HCI INTENDS TO REVIEW ITS INVESTMENTS IN THE COMPANY ON A CONTINUING BASIS AND DEPENDING UPON VARIOUS FACTORS, INCLUDING WITHOUT LIMITATION, THE COMPANY'S FINANCIAL POSITION AND STRATEGIC DIRECTION, OVERALL MARKET CONDITIONS, OTHER INVESTMENT OPPORTUNITIES AVAILABLE TO HCI AND ITS AFFILIATES, AND THE AVAILABILITY OF COMPANY SECURITIES AT PRICES THAT WOULD MAKE THE PURCHASE OR SALE OF COMPANY SECURITIES DESIRABLE, HCI MAY FROM TIME TO TIME (IN THE OPEN MARKET OR IN PRIVATE TRANSACTIONS) BUY, SELL (INCLUDING THROUGH SHORT SALES), COVER, HEDGE OR OTHERWISE CHANGE THE FORM OR SUBSTANCE OF ANY OF ITS INVESTMENTS (INCLUDING COMPANY SECURITIES) TO ANY DEGREE IN ANY MANNER PERMITTED BY LAW AND EXPRESSLY DISCLAIMS ANY OBLIGATION TO NOTIFY OTHERS OF ANY SUCH CHANGES, EXCEPT TO THE EXTENT REQUIRED BY APPLICABLE LAW. HCI ALSO RESERVES THE RIGHT TO TAKE ANY ACTIONS WITH RESPECT TO ITS INVESTMENTS IN THE COMPANY AS IT MAY DEEM APPROPRIATE. HCI HAS NOT SOUGHT OR OBTAINED CONSENT FROM ANY THIRD PARTY TO USE ANY STATEMENTS OR INFORMATION CONTAINED HEREIN. ANY SUCH STATEMENTS OR INFORMATION SHOULD NOT BE VIEWED AS INDICATING THE SUPPORT OF SUCH THIRD PARTY FOR THE VIEWS EXPRESSED HEREIN. View original content to download multimedia: https://www.prnewswire.com/news-releases/humanco-investments-sends-letter-to-the-board-of-directors-of-grove-collaborative-302500563.html SOURCE HumanCo Investments
  Content Reference URL	None

• Publisher

  Publisher Name	Cadillac News (#5837)
  Publisher URL	https://www.cadillacnews.com
  Description	None
  Trust Flow Score	56
  Citation Flow Score	36

• Data Source

  Data Source Name	Quantexa News (#5)
  Data Source Type	news
  Data Source URL	https://app.aylien.com/dashboard
  Description	Welcome to Quantexa News API — the most powerful way to aggregate, filter, and integrate global news data into your apps and models.
  Weight	10